AVGO
57
-14
DE
29
-3
SCHW
49
3
KSS
43
4
SLB
48
2
AVB
72
3
FIS
50
-3
TGNA
58
4
CA
40
4
WEC
45
9
GILD
50
13
EW
40
2
ADBE
66
4
URBN
70
4
GE
65
-2
HAL
41
11
FOX
30
2
VMC
57
3
PDCO
57
2
SWN
30
-12
AVGO
57
-14
DE
29
-3
SCHW
49
3
KSS
43
4
SLB
48
2
AVB
72
3
FIS
50
-3
TGNA
58
4
CA
40
4
WEC
45
9
GILD
50
13
EW
40
2
ADBE
66
4
URBN
70
4
GE
65
-2
HAL
41
11
FOX
30
2
VMC
57
3
PDCO
57
2
SWN
30
-12
Financhill
Back

DocuSign Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
91

DOCU
DocuSign

Last Price:
52.79
Seasonality Move:
-0.76%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
91
DocuSign (DOCU) is a Buy

Is DocuSign a Buy, Sell or Hold?

  • The current DocuSign [DOCU] share price is $52.74. The Score for DOCU is 91, which is 82% above its historic median score of 50, and infers lower risk than normal.
  • DOCU is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DOCU Stock Price Chart

What is DocuSign's stock price today?

  • The DocuSign share price today is $52.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DOCU is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

DOCU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.6 Sell
Relative Strength Index (14 RSI): 43.47 Sell
Chaikin Money Flow: 4426127 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.43 - 58.05) Sell
Bollinger Bands (100): (52.59 - 59.35) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

DOCU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.54 Buy
20-day SMA: 53.5 Sell
50-day SMA: 56.35 Sell
200-day SMA: 52.15 Buy
8-day EMA: 51.99 Buy
20-day EMA: 53.39 Sell
50-day EMA: 55.28 Sell
200-day EMA: 54.86 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

DocuSign Earnings Growth & DOCU Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.05 per share, an increase this year of $0.96 per share, and an increase next year of $0.37 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

DocuSign Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):